FMR LLC raised its position in MetLife, Inc. (NYSE:MET - Free Report) by 6.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,362,251 shares of the financial services provider's stock after acquiring an additional 153,132 shares during the quarter. FMR LLC owned approximately 0.34% of MetLife worth $193,421,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in MET. Sierra Ocean LLC bought a new stake in MetLife during the 4th quarter worth approximately $32,000. Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the 4th quarter valued at $32,000. Graney & King LLC bought a new stake in MetLife during the fourth quarter valued at about $34,000. Values First Advisors Inc. purchased a new position in shares of MetLife in the fourth quarter valued at about $36,000. Finally, Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of MetLife in the fourth quarter worth about $48,000. 94.99% of the stock is currently owned by institutional investors.
MetLife Trading Up 1.1 %
NYSE:MET traded up $0.79 during mid-day trading on Friday, hitting $72.49. 2,739,216 shares of the stock traded hands, compared to its average volume of 3,404,801. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $49.38 billion, a price-to-earnings ratio of 12.14, a PEG ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The firm's 50 day moving average is $79.41 and its two-hundred day moving average is $82.19.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on MET shares. Wells Fargo & Company lowered their price target on MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price for the company. Piper Sandler lifted their price target on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Cowen reissued a "buy" rating on shares of MetLife in a report on Friday, March 7th. Finally, UBS Group lifted their target price on MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $92.46.
Check Out Our Latest Stock Analysis on MetLife
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.